SC 13G Filing

Company

Sonoma Pharmaceuticals, Inc.

Filed

May 15, 2009

Accession Number

0000929638-09-000897

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →